Compare Moderna, Inc. (MRNA) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance

Moderna, Inc.Trade

Invesco NASDAQ 100 ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Invesco NASDAQ 100 ETF — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Invesco NASDAQ 100 ETF trades at $291.56. The key difference: Invesco NASDAQ 100 ETF is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

	MRNA	QQQM
Market Cap	$23.60B	—
Sector	Health	Broad Market / Factor
52-Week High	$81.80	$307.23
52-Week Low	$22.36	$228.02
Enterprise Value	$19.70B	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Moderna, Inc.

Moderna (MRNA) trades at $59.66, down 3.49% in the last session amid broader biotech volatility. The stock shows a mixed technical picture with bullish overall signals but bearish moving averages. Fundamentally, revenue has declined from pandemic peaks to $1.92B in 2025, with net losses widening to -$2.82B. Recent positive developments include an EU RSV vaccine contract and progress in cancer immunotherapy trials, with Q2 2026 earnings due July 31.

Outlook remains speculative as Moderna transitions beyond COVID-19 vaccines. Opportunities lie in its expanding pipeline in oncology and flu vaccines, but risks include sustained losses, competitive pressure, and execution hurdles. Analyst consensus is cautious with a $49 price target below current levels, reflecting uncertainty over profitability timeline.

Invesco NASDAQ 100 ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

QQQM

Investors poured billions into South Korea ETFs and semiconductors amid market shifts last week.ETF Trends · 1 day agoBullish Invesco Nasdaq 100 ETF (QQQM) hits $100B AUM, remains top growth index fund despite new cheaper rivals.ETF Trends · 1 day agoBullish Four ETFs near $100B milestone, highlighting investor demand for growth, dividends, safety, and diversification.ETF Trends · 1 day agoBullish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Invesco NASDAQ 100 ETF

QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.